Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Titel:
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
Auteur:
Harper, Diane M Franco, Eduardo L Wheeler, Cosette M Moscicki, Anna-Barbara Romanowski, Barbara Roteli-Martins, Cecilia M Jenkins, David Schuind, Anne Costa Clemens, Sue Ann Dubin, Gary